rs3802758
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004813.4(PEX16):c.542-16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.87 in 1,608,200 control chromosomes in the GnomAD database, including 621,438 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.79 ( 49021 hom., cov: 34)
Exomes 𝑓: 0.88 ( 572417 hom. )
Consequence
PEX16
NM_004813.4 intron
NM_004813.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.834
Publications
23 publications found
Genes affected
PEX16 (HGNC:8857): (peroxisomal biogenesis factor 16) The protein encoded by this gene is an integral peroxisomal membrane protein. An inactivating nonsense mutation localized to this gene was observed in a patient with Zellweger syndrome of the complementation group CGD/CG9. Expression of this gene product morphologically and biochemically restores the formation of new peroxisomes, suggesting a role in peroxisome organization and biogenesis. Alternative splicing has been observed for this gene and two variants have been described. [provided by RefSeq, Jul 2008]
PEX16 Gene-Disease associations (from GenCC):
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 8A (Zellweger)Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
- peroxisome biogenesis disorder 8BInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 11-45914484-G-A is Benign according to our data. Variant chr11-45914484-G-A is described in ClinVar as Benign. ClinVar VariationId is 259546.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.91 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.786 AC: 119480AN: 152028Hom.: 49004 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
119480
AN:
152028
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.801 AC: 197084AN: 246036 AF XY: 0.821 show subpopulations
GnomAD2 exomes
AF:
AC:
197084
AN:
246036
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.879 AC: 1279385AN: 1456054Hom.: 572417 Cov.: 58 AF XY: 0.880 AC XY: 637714AN XY: 724562 show subpopulations
GnomAD4 exome
AF:
AC:
1279385
AN:
1456054
Hom.:
Cov.:
58
AF XY:
AC XY:
637714
AN XY:
724562
show subpopulations
African (AFR)
AF:
AC:
19223
AN:
33466
American (AMR)
AF:
AC:
26185
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
AC:
22436
AN:
26124
East Asian (EAS)
AF:
AC:
15132
AN:
39690
South Asian (SAS)
AF:
AC:
73969
AN:
86234
European-Finnish (FIN)
AF:
AC:
44962
AN:
47966
Middle Eastern (MID)
AF:
AC:
4969
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1020905
AN:
1111798
Other (OTH)
AF:
AC:
51604
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
8457
16914
25372
33829
42286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21296
42592
63888
85184
106480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.786 AC: 119539AN: 152146Hom.: 49021 Cov.: 34 AF XY: 0.785 AC XY: 58415AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
119539
AN:
152146
Hom.:
Cov.:
34
AF XY:
AC XY:
58415
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
24372
AN:
41466
American (AMR)
AF:
AC:
10724
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
2958
AN:
3470
East Asian (EAS)
AF:
AC:
2219
AN:
5118
South Asian (SAS)
AF:
AC:
4119
AN:
4826
European-Finnish (FIN)
AF:
AC:
10038
AN:
10622
Middle Eastern (MID)
AF:
AC:
247
AN:
294
European-Non Finnish (NFE)
AF:
AC:
62328
AN:
68022
Other (OTH)
AF:
AC:
1689
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1125
2250
3375
4500
5625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
854
1708
2562
3416
4270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2446
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:3
Oct 21, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Aug 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Peroxisome biogenesis disorder 8B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Peroxisome biogenesis disorder Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Peroxisome biogenesis disorder 8A (Zellweger) Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.